Loading stock data…
SRTA
$5.50+0.03 (+0.46%)
Market OpenUpdated 12:43 PM EDT
Strata Critical Medical, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Strata Critical Medical, Inc. in the Healthcare sector is trading at $5.50. Wall Street consensus targets $8.88 (4 analysts), implying a +61.5% move over the next 12 months. The stock is currently near its 52-week high of $6.02, remaining 15.9% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +61.5% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Sector + growth-aware fair-multiple estimate. Fair P/E = sector-anchor + (ROE × 25) + (max(revenue growth, earnings growth) × 30), capped at 1.6× sector. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. The sector anchor (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) keeps quality compounders from being mechanically penalized against utility multiples. Result is a normalised multiple gauge — not a price target.
Current Price$5.50
Potential Downside
0%
Whystock Fair Value$5.50
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground tr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$414.08M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.11
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-13.23%
Volume
Today's trading volume
570,474
Recent News
Strata Critical Medical, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Investors in Strata Critical Medical, Inc. ( NASDAQ:SRTA ) had a good week, as its shares rose 6.4% to close at US$5.34...
Joby Keeps Losing Money—and the Stock Keeps Rising
Joby Aviation reported better-than-expected first-quarter sales. Joby is still, essentially, presales. Joby stock gained 21% to $10.52 on Wednesday, while the and rose 1.5% and 1.2%, respectively.
Strata Critical Medical, Inc. Q1 2026 Earnings Call Summary
Moby summary of Strata Critical Medical, Inc.'s Q1 2026 earnings call
Strata (SRTA) Q1 2026 Earnings Call Transcript
Mathew Schneider: Thank you for standing by, and welcome to Strata's conference call and webcast for the quarter ended March 31, 2026. Before we get started, I would like to remind you of the company's forward-looking statement and safe harbor language. Statements made in this conference call that are not historical facts, including statements about future time periods, may be deemed to constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
How The Story Is Shifting For Strata Critical Medical (SRTA) After The Lower Fair Value Target
The analyst fair value target for Strata Critical Medical has shifted from US$9.63 to US$8.81, pointing to a more measured view of where the shares might reasonably trade. This revision sits alongside largely constructive research coverage, with firms updating their models while still focusing on how well management delivers against its current plan. As you read on, you will see how this evolving price target fits into the broader story and what to watch as the narrative develops. Analyst...